{"id":"W2147371554","doi":"10.1016/j.jalz.2014.07.123","title":"P4‐353: A PHASE 2 TRIAL OF THE EFFICACY AND SAFETY OF THE ALPHA7 AGONIST ABT‐126 AS AN ADD‐ON TREATMENT IN MILD‐TO‐MODERATE ALZHEIMER'S DEMENTIA","year":2014,"lang":"en","type":"article","venue":"Alzheimer s & Dementia","topic":"Nicotinic Acetylcholine Receptors Study","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Donepezil; Rivastigmine; Placebo; Medicine; Dementia; Internal medicine; Adverse effect; Randomized controlled trial; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001047818,0.001857445,0.001380816,0.0003538659,0.0004023172,0.0007546724,0.0007758056,0.001390914,0.005585689],"category_scores_gemma":[0.000690683,0.0005209523,0.001118325,0.0002584644,0.0006719035,0.0005162971,0.0003264264,0.002567996,0.001318797],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005837356,"about_ca_system_score_gemma":0.001283084,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001336916,"about_ca_topic_score_gemma":0.002791361,"domain_scores_codex":[0.9997541,0.0001001461,0.00001121075,0.00004372661,0.00002806606,0.00006278146],"domain_scores_gemma":[0.9997421,0.00003849771,0.00004128685,0.00001812564,0.00002203707,0.0001380195],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8287055,0.03645678,0.001863973,0.0009390851,0.001181654,0.0004427518,0.0002111011,0.0008987609,0.04955596,0.0003939127,0.009031089,0.07031943],"study_design_scores_gemma":[0.774361,0.2136208,0.005025969,0.00002852311,0.0003848461,0.0002502205,0.00003439281,0.0008725142,0.003270979,0.0002828826,0.001834439,0.0000333873],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9899588,0.001341072,0.0005083719,0.0005341361,0.000165173,0.002697028,0.001913316,0.0002727546,0.002609224],"genre_scores_gemma":[0.983519,0.001508351,0.001821659,0.001325575,0.0001851577,0.003076957,0.003047837,0.00005801339,0.005457432],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005585689,"threshold_uncertainty_score":0.01868606,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02208091086731606,"score_gpt":0.3081977617240162,"score_spread":0.2861168508567001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}